Results 101 to 110 of about 15,960 (226)

Achieving Representation in Cardiovascular Device Clinical Research: The Role of Regulatory Science. [PDF]

J Soc Cardiovasc Angiogr Interv
Batchelor WB, Coylewright M, Jamil Y, White R, Spitzer E, Hanafi N, Jaff MR, Chapman R, Stephens D, Krucoff MW.   +9 more
europepmc   +1 more source

Making Employee Health Benefits Understandable: The Summary-Plan-Description Failure and How to Fix It

SSRN Electronic Journal, 2022
openaire   +2 more sources

Anti‐CD19 CAR T Cells in Autoimmune Encephalitis: Inflammation Controlled, Neurodegeneration Unchecked?

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Just recently, successful chimeric antigen receptor (CAR) T cell therapy was reported in the first patient with refractory, anti‐diacylglycerol lipase alpha (DAGLA) antibody‐mediated autoimmune encephalitis, achieving partial clinical remission.
Dimitrios Mougiakakos, Marwa Al‐Dubai, Denise Walther, Dominic Borie, Jan D. Lünemann, Marc Pawlitzki, Sven G. Meuth, Solveig Henneicke, Stefan Vielhaber, Stefanie Schreiber   +9 more
wiley   +1 more source

Employee retention for subscribers with and without an obesity diagnosis in self-insured employer health plans: A claims-based analysis. [PDF]

J Manag Care Spec Pharm
Naber J, Kuester M, Chmura L, Vallarino C, Ward J, Tian H, Dell S, Xue J.   +7 more
europepmc   +1 more source

CAR T‐Cell Therapy in Neurology: A Scoping Review of Neuro‐Oncology, Autoimmune Diseases & Neurotoxicity

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Chimeric antigen receptor (CAR) T‐cell therapy has been investigated in neurological diseases, encompassing both central nervous system malignancies and autoimmune disorders, thereby extending its application beyond hematological cancers.
Omar Alqaisi, Mohammed Dibas, Patricia Tai, Ala Dibas, Osama Souied, Suhair Al‐Ghabeesh   +5 more
wiley   +1 more source

AMCP Market Insights: Getting to the heart of hard-to-control hypertension in managed care. [PDF]

J Manag Care Spec Pharm
Flavin B, Wolff D, Gandhi G, Pourarsalan H, Rader F, Richardson T, Shannon M, Spence S, Wescott S.   +8 more
europepmc   +1 more source

Spatial and Volumetric Characteristics of Glioblastoma: Associations With Clinical Presentation and Survival

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective We aim to comprehensively analyze how regional tumor and edema characteristics are associated with clinical presentations and survival outcomes in a large cohort of glioblastoma patients. Methods Patients with IDH‐wildtype glioblastoma who received brain MRI from 2010 to 2023 were included.
Daniel J. Zhou, Marc Jaskir, Julian Gal, Yombe Fonkeu, Christos Davatzikos, MacLean P. Nasrallah, Jose Garcia, Rubo Xing, Stephen J. Bagley, Arati Desai, Richard E. Phillips, Steven Tobochnik, Colin A. Ellis, James J. Gugger, Nishant Sinha, Joel M. Stein, Kathryn A. Davis   +16 more
wiley   +1 more source

Protecting Against Unintended Risk From Student Quality Improvement Projects in Health Care. [PDF]

Adv Health Inf Sci Pract
Bryant-Gawthrop I.
europepmc   +1 more source

Long‐Term Efficacy of Immunotherapy in Autoimmune Autonomic Ganglionopathy—A 10‐Year Follow Up Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Autoimmune autonomic ganglionopathy (AAG) is a rare but potentially treatable cause of severe autonomic failure. Evidence guiding long‐term immunotherapy, treatment sequencing, and residual autonomic impairment is limited. We evaluated long‐term treatment response, residual autonomic dysfunction, and relapse patterns in patients with
Giacomo Chiaro, Shiwen Koay, Gordon T. Ingle, Patricia McNamara, Laura Watson, Fion Bremner, Valeria Iodice   +6 more
wiley   +1 more source

System changes to empower primary care in Alzheimer's disease detection and care. [PDF]

Alzheimers Dement
Phares S, Kremer I, Wall JK, Wood J, Baumgart M, Dickson S, Fickie M, Hubbard T, Jannati A, Monane M, Rivet C, Hirsch G.   +11 more
europepmc   +1 more source